arXiv paper· cardiac bioelectronics / microphysiological sensing· empirical study

Optical microelectrode arrays for differential readout of electrical and mechanical signals in cardiac cells

Alessandro Leronni, Rosalia Moreddu

q-bio.QM · q-bio.CB

Quick verdict

A paired contact/non-contact optical microelectrode array plausibly separates charge-mirroring from contraction-driven components in cardiac fluorescence traces, but the separation rests on one pharmacological manipulation with no independent ground truth.

Summary

The authors report a silicon-nitride membrane device carrying arrays of 3D gold microelectrodes that separate two contributions to a fluorescence readout taken from beating human iPSC-derived cardiomyocytes. Each sensing unit pairs a central contact electrode touching the cell with a concentric non-contact electrode on the lower face of the membrane that only senses membrane displacement. Rhodamine 6G dispersed in ethylene glycol fills the lower chamber and is imaged confocally at 30 fps; contact and non-contact traces come from concentric regions of interest and are normalized to the contact electrode range. In drug-free spontaneously beating cultures both channels show matched periodic events. After 5 uM blebbistatin, the non-contact channel collapses toward the cell-free noise floor while rhythmic events persist at the contact electrode. The authors read the surviving contact signal as action-potential-driven charge mirroring and the blebbistatin-sensitive component as contractility. Mean waveforms average 48 detected events from 12 electrodes in 3 devices; measured peak-to-peak amplitudes (0.15 electrical, 0.26 electromechanical, 0.18 mechanical) track finite-element Poisson-Nernst-Planck predictions to within constant factors of 4.3 to 6. Statistics are essentially absent: no tests, effect sizes or intervals beyond one baseline-offset figure of 4.89 +/- 0.47 percent. The work is a mechanism proof, not a calibrated assay: it recovers neither absolute membrane voltage nor contractile force.

Review complete

Assessment at a glance

cardiac bioelectronics / microphysiological sensing

5

risk flags identified

● high 1

● medium 3

● low 1

Reproducibility readinesslow
Code & data availablenot stated
Review confidencemedium
Deep research viable

5 strengths · 5 weaknesses · 5 author questions

Levels reflect verification complexity — not a quality score. Evolve never rates your paper.

Key claims under review

  • The fluorescence signal at a membrane-integrated microelectrode in contact with a cardiac cell contains two separable contributions: action-potential-driven charge redistribution and contraction-driven membrane displacement.
  • A concentric non-contact electrode within the same sensing unit functions as a predominantly mechanical reporter, while the contact electrode carries the composite electromechanical signal.
  • Suppressing contraction with 5 uM blebbistatin isolates the electrical component, which persists at the contact electrode while the non-contact channel returns to baseline noise.
  • A coupled Poisson-Nernst-Planck finite-element model reproduces the sign, temporal ordering and waveform features of all three measured signal classes, supporting a common transduction mechanism.
  • The platform offers a label-free, microscopy-compatible route to parallel electrical and mechanical readout for cardiotoxicity screening and hiPSC-CM phenotyping.

Strengths

  • Paired contact/non-contact electrode architecture gives a genuine internal differential measurement

    Figures 2a and 3b show concentric square features with the contact electrode inside a non-contact frame in the same unit; because the two ROIs are concentric and micrometres apart they share illumination, dye environment, focus and local cell environment, which removes the confound that usually plagues single-channel intensity comparisons (Materials and methods, Data analysis; Figure S6 quantifies the residual 4.89 +/- 0.47% baseline offset).

  • Cell-free and pharmacological controls bracket the claimed signal origin

    Figure 3d shows medium-only electrode pairs produce only slow drift and low-amplitude fluctuations with no periodic transients, excluding artifacts from the optics, perfusion or fluorophore; Figure 3f applies 5 uM blebbistatin, a standard excitation-contraction uncoupler, and shows the non-contact channel revert to that noise level while the contact channel keeps firing.

  • Quantitative multiphysics model is tied to the measurements rather than decorative

  • Honest, specific statement of what the method does NOT deliver

  • Device fabrication builds on previously published, reproducible recipes

Weaknesses

  • No independent ground truth for the electrical channel

  • No inferential statistics anywhere in the Results

  • Model overpredicts absolute amplitude by 4.3-6x and this is passed off as agreement

  • 30 fps confocal acquisition cannot resolve action-potential kinetics

  • Notch-filter-free normalization to the contact channel complicates cross-unit comparison

Full Review Report

$1.99 · one-time

Unlock the complete preliminary analysis Evolve produced for this paper.

Report preview

Scope & Claims

The paper asks a narrow but genuinely useful question: when a cardiac cell sits on a membrane-based optical microelectrode, does the fluorescence readout contain separately identifiable electrical and mechanical contributions? The claim advanced is yes, and that a paired contact/non-contact electrode geometry makes the split accessible without labels. Every abstract promise is anchored to that mechanism claim: simultaneous assessment of excitation and contraction, a label-free route to high-throughput cardiotoxicity screening, and clarification of the physics behind membrane-based optical devices used with cardiac cells.

The evidence delivered matches the mechanism claim far better than the application claim. Nothing in the Results section tests a screening workflow; the only compound administered is blebbistatin at 5 uM, used as an uncoupling tool rather than as a cardiotoxic challenge. The abstract's move from "separable contributions" to "cardiotoxicity screening" therefore rests on untested extrapolation, and readers should weight the two parts very differently.

The remaining sections cover Methodology Assessment, Statistical Evidence, Results & Reproducibility, Limitations & Risks, and Verdict & Recommendations.

  • All 5 strengths & 5 weaknesses, analyzed in detail
  • 5 risk flags with severity, section & reviewer questions
  • Methods & statistical evidence assessment
  • 5 questions a peer reviewer would ask
  • Full six-dimension evaluation report & recommendations

One-time purchase · this paper only

One-time purchase, this paper only. AI-generated preliminary analysis — not peer review.

Frequently asked questions

Can fluorescence readouts really distinguish electrical from mechanical activity in heart cells?

This paper argues yes, using a differential electrode geometry. Each sensor has a central contact electrode touching the cell and a surrounding electrode that only senses membrane movement. Comparing the two, plus recordings after the contraction blocker blebbistatin, lets the authors attribute one component to the action potential and another to contraction. The evidence is indirect: it rests on the drug experiment and a physics simulation, not on simultaneous voltage recording, so the claim is plausible but not yet confirmed against a gold standard.

How does the optical microelectrode array avoid needing voltage-sensitive dyes inside the cell?

The dye stays outside the cells. Rhodamine 6G sits in an ethylene-glycol-filled chamber beneath the membrane. When the cell depolarizes, charge redistribution near the gold electrode pulls the charged dye molecules toward it, changing local fluorescence; when the cell contracts, the membrane moves and physically convects dye. Both effects are read through the same optical path, so no genetic reporters or intracellular dyes touch the biology.

Is this device ready for drug safety screening, and what are its limits?

Not yet. The paper demonstrates that the two signal components can be told apart, but no drug panel is tested beyond the tool compound blebbistatin, no numbers are given for sensitivity or detection limits, and recordings run at 30 frames per second, far slower than needed for action-potential shape. It also measures relative changes rather than absolute voltage or force.

About this review

This is an AI-generated preliminary review by Evolve.Pub, produced from the openly available text of the paper. It is not peer review and does not represent the authors' views. The canonical record of the paper is at the publisher link above.

  • Only the main text was available; Figures S1-S3, S5, S6 and Supplementary Video S4 are referenced but not inspectable, so device uniformity, ROI geometry and baseline-offset statistics were assessed from their captions alone.
  • Figure 3h amplitudes were read from the paper's own quoted values rather than from the plotted data; the panel figure itself could not be measured.
  • The list of the 48 detected events across 12 electrodes does not state how many independent cell preparations contributed, so the effective biological replicate count is unknown.

Go deeper on this paper

Reproduce ResultsNot feasible for this paper — the core results cannot be re-derived by sandboxed code simulation.

Wrote a paper? Stress-test it before reviewers do.

Upload your manuscript for the same structured scrutiny — reasoning, statistics, evidence, figures, and reproducibility.

Scan your paper
Optical microelectrode arrays for differential readout of electrical and mechanical signals in cardiac cells | Evolve.Pub